Lobbyists from drugstore trade associations are pushing the limits of prescription drug profits at the expense of consumers and their drug plans, according to National Center for Policy Analysis Senior Fellow Devon Herrick.
AbbVie has won approval from the FDA for the expanded use of Viekira Pak, a combination of ombitasvir, paritaprevir, ritonavir tablets and dasabuvir tablets, without ribavirin, as a treatment for chronic hepatitis C genotype 1b patients with compensated cirrhosis.
The Campaign for Sustainable Rx Pricing, which includes insurance plans, AARP and Walmart, is pushing for lower prescription drug prices through shorter exclusivity periods for biologics, increased FDA staff to cut the backlog of generic applications and greater cost transparency from drug manufacturers.
The federal government has released regulations governing the Medicaid managed care organizations that operate in 39 states and the District of Columbia, setting standards for provider networks, spending on medical care, fraud prevention, quality ratings and more.
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.
Contact PCMA Charles Cote
Vice President, Strategic Communications